The Burrill Report

The Burrill Report (April 11, 2011): Financing and Dealmaking Activity Soar in China (.MP3,9.42 Mb)

The market in China for life sciences IPOs ignited in 2009 and has been on a tear ever since with companies in the sector raising $5.9 billion in 2010 alone. The feverish activity isn’t limited just to new issues, but can also be seen in a surge in everything from venture financings to merger and acquisition activity. We spoke to Greg Scott, president and founder of the consulting firm ChinaBio and publisher of ChinaBio Today, about the emergence of China as a life sciences powerhouse, what’s driving the activity, and the transformation of China as merely a source of cheap labor into a provider of innovative new drugs.


April 08, 2011
http://www.burrillreport.com/article-financing_and_dealmaking_activity_soar_in_china_.html